Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China.
Drugs of plant origin have received much attention due to their enormous potential for the prevention and treatment of cancer. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China is reviewed in this paper, with particular emphasis on taxol, daidzein, acetyl boswellic acid, curcumin and ginsenosid Rh2.
Han
R
R
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing.
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal / Q000737:chemistry; D006801:Humans; D007155:Immunologic Factors; D008516:Medicine, Chinese Traditional; D017239:Paclitaxel / Q000494:pharmacology
D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal; D007155:Immunologic Factors; D017239:Paclitaxel